Breast Cancer
FY21 Breakthrough Award - Funding Level 2 - Partnering PI Option
The list of Fiscal Year 2021 Breast Cancer Research Program Breakthrough Award - Funding Level 2 - Partnering PI Option applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
| Institution | Principal Investigator |
|---|---|
| Cedars-Sinai Medical Center | Simon Knott |
| MD Anderson Cancer Center | Guang Peng |
| MD Anderson Cancer Center | Timothy Yap |
| Nuvox Pharma, LLC | Evan Unger |
| University of Arizona | Pavani Chalasani |
| University of Chicago | Alexander Pearson |
| University of Chicago | Dezheng Huo |
| University of Kansas Medical Center Research Institute, Inc. | Priyanka Sharma |
| University of Kansas Medical Center Research Institute, Inc. | Shane Stecklein |
| University of Texas Health Science Center at Houston | Ali Azhdarinia |
| University of Texas Health Science Center at Houston | Mikhail Kolonin |
| Vanderbilt University | Fiona Yull |
| Vanderbilt University Medical Center | Julie Sterling |
| Virginia Commonwealth University | Guizhi Zhu |
| Virginia Commonwealth University | Masoud Manjili |
| Weill Cornell Medical College | Lorenzo Galluzzi |
Last updated Thursday, February 17, 2022